The emerging treatment of the medication represents a significant development in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – leading https://tirzepatidepeptide333440.targetblogs.com/42385953/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment